Successful treatment of subcutaneous Purpureocillium lilacinum infection with fosravuconazole

J Dermatol. 2023 Mar;50(3):e104-e105. doi: 10.1111/1346-8138.16631. Epub 2022 Nov 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antifungal Agents / therapeutic use
  • Humans
  • Hypocreales*

Substances

  • Antifungal Agents

Supplementary concepts

  • Purpureocillium lilacinum

Associated data

  • RefSeq/MH165846
  • RefSeq/MN200345